H. Müller

K. Heinimann, A. Russell, M. Plášilová, 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?

L. Kappos, P. Fuhr, S. Rüegg, 2005, Swiss medical weekly.

Hereditary conditions in which the loss of heterozygosity may be important.

R. Scott, H. Müller, R. Scott, 1992, Mutation research.

Nontruncating APC Germline Mutations and Mismatch Repair Deficiency Play a Minor Role in APC Mutation-negative Polyposis 1

G. Marra, K. Heinimann, D. Foernzler, 2001 .

A de Novo PABPN1 Germline Mutation in a Patient with Oculopharyngeal Muscular Dystrophy

K. Heinimann, N. Gürtler, M. Plášilová, 2006, The Laryngoscope.

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

P. Møller, G. Capellá, A. Lindblom, 2010, Familial Cancer.

Strictly defined familial male breast cancer

U. Güth, D. Huang, E. Obermann, 2011, Familial Cancer.

N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers.

P. Chappuis, P. Hutter, R. Scott, 1999, Cancer research.

Loss of the Y chromosome from bone marrow cells of males with myeloproliferative disorders. Report of two cases and review of the literature.

B. Speck, G. Stalder, H. Müller, 1977, Acta Haematologica.

Variant of the Fluorescence Pattern in an Abnormal Human Y Chromosome

G. Stalder, H. Müller, E. Bühler, 1971, Nature.

Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.

C. Albrecht, K. Heinimann, P. Bauerfeind, 2002, Anticancer research.

J. Boyle, M. Häner, H. Müller, 1989, Experimental cell research.

Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families

J. Mecklin, J. Utsunomiya, H. Lynch, 1993, Diseases of the colon and rectum.

Disease expression in Swiss hereditary non‐polyposis colorectal cancer (HNPCC) kindreds

K. Heinimann, W. Weber, H. Müller, 1997, International journal of cancer.

Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis

R. Scott, Z. Dobbie, H. Müller, 1996, Human Genetics.

Germline alterations in the cyclooxygenase‐2 gene are not associated with the development of extracolonic manifestations in a large Swiss familial adenomatous polyposis kindred

H. Müller, Z. Dobbie, I. Bendik, 2000, International journal of cancer.

Histopathological Aspects of Familial Breast Cancer1

J. Torhorst, W. Weber, H. Müller, 1990 .

Association of Extracolonic Manifestations of Familial Adenomatous Polyposis with Acetylation Phenotype in a Large FAP Kindred

R. Scott, U. Meyer, K. Heinimann, 1997, European journal of human genetics : EJHG.

Banding techniques in the evaluation of human chromosomal variants

G. Stalder, H. Müller, E. Bühler, 1973, Humangenetik.

Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis.

G. Marra, K. Heinimann, D. Foernzler, 2001, Cancer research.

Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.

C. Albrecht, K. Heinimann, P. Tondelli, 2002, Anticancer Research.

A polymorphism in the ATM gene modulates the penetrance of hereditary non‐polyposis colorectal cancer

P. Chappuis, P. Hutter, A. Sappino, 2000, International journal of cancer.

Dominant inheritance in human cancer.

H. Müller, 1990, Anticancer research.

[Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling].

J. Mary, M. Spycher, W. Weber, 1993, Swiss medical weekly.